Suzano S.A. 2025 Annual Report (Form 20-F) Summary
Business Context and Reporting Period
This summary covers the fiscal year ended December 31, 2025, for Suzano S.A., a Brazilian vertically integrated producer of pulp and paper. The company operates primarily in Brazil with significant export markets in Asia, Europe, and North America. Key operational highlights for 2025 include the completion of the Cerrado Project (Ribas do Rio Pardo mill), the acquisition of Pactiv Evergreen assets in the U.S. (Suzano Packaging), and the inauguration of a new tissue facility in Aracruz. The company reported a return to profitability, driven by strong financial results from exchange rate variations and derivatives, despite lower pulp prices.
Key Financial Metrics (Year Ended Dec 31, 2025)
| Metric | 2025 (R$ Million) | 2024 (R$ Million) | Change |
|---|---|---|---|
| Net Sales | 50,116 | 47,403 | +5.7% |
| Gross Profit | 16,226 | 20,002 | -18.9% |
| Operating Profit | 10,649 | 15,691 | -32.1% |
| Net Financial Income | 9,762 | (28,802) | Turnaround to Gain |
| Net Income | 13,438 | (7,045) | +290.7% |
| Adjusted EBITDA | 21,736 | 23,849 | -8.9% |
| Operating Cash Flow | 18,152 | 20,604 | -11.9% |
| Total Debt | 94,801 | 101,436 | -6.5% |
| Cash & Equivalents | 15,180 | 9,019 | +68.3% |
Note: All figures are in Brazilian Reais (R$) unless otherwise noted. Net income includes significant non-operating financial gains.
Material Changes vs. Prior Period
- Revenue Mix: Pulp sales remained relatively flat (+0.6%) due to a 15.6% decrease in average pulp prices (US$542/ton vs. US$644/ton in 2024), partially offset by a 15% volume increase. Paper sales surged 25.4% to R$12.3 billion, driven by the consolidation of Suzano Packaging US operations.
- Profitability: Operating profit declined 32.1% due to lower pulp prices and higher costs. However, Net Income swung from a loss of R$7.0 billion in 2024 to a profit of R$13.4 billion in 2025. This reversal was primarily driven by a R$9.8 billion net financial gain (vs. R$28.8 billion loss in 2024), resulting from favorable exchange rate variations (R$7.6 billion gain) and derivative instruments (R$7.3 billion gain).
- Cost Structure: Cost of sales increased 23.7% due to higher volumes and currency appreciation, though production costs per unit decreased.
- Divestitures: The company recognized significant losses from associates and joint ventures (R$409 million) due to the divestment of Woodspin Oy and Ensyn Corporation interests.
Guidance, Outlook, and Risks
- Capital Expenditures: The approved budget for 2026 is R$10.9 billion, a decrease from 2025, primarily due to the completion of the Cerrado Project and lower disbursements for standing wood swaps.
- Strategic Acquisitions: In June 2025, Suzano agreed to acquire a 51% stake in a new joint venture with Kimberly-Clark for the global tissue business (excluding North America), expected to close in mid-2026.
- Tax Environment: The company faces significant uncertainty regarding Brazilian tax reforms, including the implementation of a new VAT model (CBS/IBS) and the introduction of a 10% withholding tax on dividends paid to non-residents starting January 1, 2026.
- Key Risks:
- Commodity Prices: Continued volatility in global pulp prices and demand, particularly from China (41% of global demand).
- Exchange Rates: Significant exposure to the USD/BRL exchange rate, which impacts both revenue translation and debt servicing costs.
- Legal & Environmental: Ongoing litigation regarding land titles, environmental licensing, and tax assessments (R$10.4 billion in possible tax contingencies).
- Climate Change: Physical risks to biological assets (forests) from droughts, fires, and pests.
Investor Verification Checklist
- Financial Quality: Verify the sustainability of the 2025 net income, noting it is heavily reliant on non-recurring financial gains (exchange/derivatives) rather than core operating margins, which declined.
- Debt Profile: Review the maturity schedule of the R$94.8 billion debt, specifically the portion denominated in USD, to assess refinancing risks in a high-interest-rate environment.
- Tax Contingencies: Assess the potential impact of the R$10.4 billion in "possible" tax contingencies and the implications of the new Brazilian dividend withholding tax on future shareholder returns.
- Kimberly-Clark Deal: Monitor the regulatory approval status and closing timeline of the 51% tissue joint venture, which is a key growth driver for 2026.
- Biological Assets: Review the valuation assumptions (discount rates, wood prices) for the R$26.1 billion in biological assets, which are measured at fair value and sensitive to climate and market variables.